February 18, 2026 12:21 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Actor Rajpal Yadav granted interim bail in ₹9-crore cheque bounce case | Learn AI or become redundant: Microsoft India President issues stark message | India’s wholesale inflation rises to 1.81% in January as manufacturing prices surge | 'India at forefront of AI revolution': PM Modi welcomes world leaders to Delhi summit | Rs 5,000 to women ahead of Tamil Nadu polls! Vijay slams Stalin, says: ‘take the money, blow the whistle’ | Modi congratulates Tarique Rahman as BNP clinches majority in Bangladesh polls | Bangladesh Polls: Tarique Rahman-led BNP secures 'absolute majority' with 151 seats in historic comeback | BJP MP files notice to cancel Rahul Gandhi's Lok Sabha membership, seeks life-long ban | Arrested in the morning, out by evening: Tycoon’s son walks free in Lamborghini crash case | ‘Why should you denigrate a section of society?’: Supreme Court pulls up ‘Ghooskhor Pandat’ makers
Mansukh Mandaviya | WHO
Mansukh Mandaviya | WHO

Health Minister Mansukh Mandaviya meets WHO chief scientist to discuss Covaxin approval

| @indiablooms | Aug 13, 2021, at 05:47 am

New Delhi/IBNS: Union Health Minister Mansukh Mandaviya on Thursday met World Health Organisation (WHO) Chief Scientist Dr Soumya Swaminathan to hold discussion over the global health body's approval for Bharat Biotech's COVID-19 vaccine Covaxin.

He also informed that the WHO chief scientist lauded India's effort in combating COVID-19.

In a tweet, Mandaviya said: "Held a meeting with Dr Soumya Swaminathan, Chief Scientist of @WHO. We had a productive discussion on WHO's approval of @BharatBiotech''s COVAXIN. @DoctorSoumya also appreciated India's efforts for the containment of #COVID19."

Earlier in May, Bharat Biotech had said regulatory approvals for its indigenously developed Covid-19 vaccine are in process in more than 60 countries including the US, Brazil and Hungary.

Emergency use authorisations (EUA) have been obtained from 13 countries with more to follow, Bharat Biotech had informed.

It had also submitted an application to the WHO to get a EUL (Emergency Use Listing) for indigenously developed Covid-19 vaccine Covaxin and regulatory approvals are expected by Jul-Sept 2021.

The indigenous Covaxin vaccine is co-developed by Bharat Biotech and ICMR, Dr Raches said the Government placed an advanced purchase order of rupees 1500 crore and this will help our company to increase our risk appetite and that is why we are expanding to Bangalore and Gujarat.
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.